Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.187EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.187EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.187ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.187ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.187EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.187EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.187ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.187ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.170EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.170EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.170ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.170ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.170EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.170EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.170ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.170ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.232EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.232EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.232ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.232ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.232EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.232EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.232ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.232ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.84EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.177.84EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.84ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.177.84ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.177.84EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.177.84EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.177.84ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.84ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.76EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.76EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.76ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.76ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.76EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.76EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.76ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.76ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.301EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.301EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.301ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.301ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.301EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.301EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.301ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.301ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.362.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.362.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used